HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide.

Abstract
A female patient with disfiguring lupus erythematosus profundus (LEP) from the age of 13 years was found to have an isolated partial C4 deficiency, with reduced levels of both allotypes, C4A and C4B. A genetic basis for the hypocomplementaemia was confirmed by a family study of complement and HLA types which revealed heterozygous null alleles for C4A and C4B in the proband. Marked improvement in her cutaneous lesions occurred with thalidomide.
AuthorsN P Burrows, M J Walport, A H Hammond, N Davey, R R Jones
JournalThe British journal of dermatology (Br J Dermatol) Vol. 125 Issue 1 Pg. 62-7 (Jul 1991) ISSN: 0007-0963 [Print] England
PMID1873207 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Complement C4
  • Thalidomide
  • Complement C4a
  • Complement C4b
Topics
  • Adolescent
  • Complement C4 (deficiency)
  • Complement C4a (deficiency)
  • Complement C4b (deficiency)
  • Female
  • Humans
  • Panniculitis, Lupus Erythematosus (drug therapy, genetics, pathology)
  • Pedigree
  • Skin (pathology)
  • Thalidomide (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: